View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
Full-term and preterm neonates who received the antibiotic ceftriaxone (Rocephin) with calcium-containing products have had fatal reactions. In some cases, the drugs were administered concomitantly; in others the infusion lines and administration times for each drug differed. At autopsy, calcium-ceftriaxone precipitates were found in the neonates' lungs and kidneys.
Because of the risk to infants, the manufacturer has issued the following warnings:
* Don't use ceftriaxone to treat neonates who have hyperbilirubinemia, especially preterm babies.
* Don't mix or administer the drug simultaneously with calcium-containing products such as Ringer's solution-even through different infusion lines.
* Don't give calcium-containing products within 48 hours of the last administration of ceftriaxone.
You can find more information at http://www.fda.gov/medwatch/safety/2007/safety07.htm#Rocephin.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top